Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Hyaluronan synthases and methods of making and using same

a technology of hyaluronan and synthesizer, applied in the field of nucleic acid segments, can solve the problems of large size, overall amount or length of polymers formed, and the incidence of streptococcal infections is a major health and economic problem

Inactive Publication Date: 2006-09-21
WEIGEL PAUL +1
View PDF30 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

The present invention is about a functionally active hyaluronan synthase that has been modified by mutation or other means to have an altered enzymatic activity compared to a native hyaluronan synthase. The modified amino acid residues can include mutated cysteine residues that are involved in disulfide bond formation or enzymatic activity. The modified hyaluronan synthase can have an altered enzymatic activity, including increased or decreased enzymatic activities and producing HA products with different sizes. The invention also includes a host cell that expresses the modified hyaluronan synthase and a method of providing the modified hyaluronan synthase.

Problems solved by technology

The incidence of streptococcal infections is a major health and economic problem worldwide, particularly in developing countries.
The extrusion of the growing chain into the extracellular space also allows for unconstrained polymer growth, thereby achieving the exceptionally large size of HA, whereas confinement of synthesis within a Golgi or post-Golgi compartment limits the overall amount or length of the polymers formed.
High concentrations of HA within a confined lumen may also create a high viscosity environment that might be deleterious for other organelle functions.
Although the streptococcal and murine oligodendroglioma enzymes were successfully detergent-solubilized and studied, efforts to purify an active HAS for further study or molecular cloning remained unsuccessful for decades.
This led to a report claiming that the Group C streptococcal HAS had been cloned, which was unfortunately erroneous.
Despite these efforts, progress in understanding the regulation and mechanisms of HA synthesis was essentially stalled, since there were no molecular probes for HAS mRNA or HAS protein.
Unfortunately, several studies have employed antibodies to this uncharacterized 52-kDa streptococcal protein to investigate what was believed to be eukaryotic HAS.
It is generally felt that isolation of HA from rooster combs is laborious and difficult, since one starts with HA in a less pure state.
Unfortunately, very high molecular weight HA, such as that ranging up to 107, has been difficult to obtain by currently available isolation procedures.
However, to date the involvement of one or more of these conserved Cys residues in enzyme activity or disulfide bond formation has not been determined.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Hyaluronan synthases and methods of making and using same
  • Hyaluronan synthases and methods of making and using same
  • Hyaluronan synthases and methods of making and using same

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

="d_n">[0070] Before explaining at least one embodiment of the invention in detail, it is to be understood that the invention is not limited in its application to the details of construction and the arrangement of the components set forth in the following description or illustrated in the drawings. The invention is capable of other embodiments or of being practiced or carried out in various ways. Also, it is to be understood that the phraseology and terminology employed herein is for the purpose of description and should not be regarded as limiting.

[0071] As used herein, the term “nucleic acid segment” and “DNA segment” are used interchangeably and refer to a DNA molecule which has been isolated free of total genomic DNA of a particular species. Therefore, a “purified” DNA or nucleic acid segment as used herein, refers to a DNA segment which contains a Hyaluronate Synthase (“HAS”) coding sequence yet is isolated away from, or purified free from, unrelated genomic DNA of the source c...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
flow rateaaaaaaaaaa
Tmaaaaaaaaaa
temperatureaaaaaaaaaa
Login to View More

Abstract

A functionally active hyaluronan synthase having at least one modified amino acid residue therein as compared to a corresponding functionally active native hyaluronan synthase such that the functionally active hyaluronan synthase has an altered enzymatic activity as compared to the corresponding functionally active native hyaluronan synthase is disclosed. Methods of producing hyaluronic acid utilizing a recombinant host cell having an expression construct encoding the functionally active hyaluronan synthase with altered enzymatic activity are also disclosed.

Description

CROSS-REFERENCE TO RELATED APPLICATIONS [0001] This application is a continuation of U.S. Ser. No. 10 / 309,560, filed Dec. 3, 2002; which claims benefit under 35 U.S.C. 119(e) of U.S. Ser. No. 60 / 336,105, filed Dec. 3, 2001; the contents of which are hereby expressly incorporated herein by reference. [0002] Said U.S. Ser. No. 10 / 309,560 is also a continuation-in-part of U.S. Ser. No. 10 / 011,771, filed Dec. 11, 2001; the contents of which are hereby expressly incorporated herein by reference.STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT [0003] This application was supported in part by a grant from the National Institutes of Health (GM35978). The United States Government may have rights in and to this application by virtue of this funding.BACKGROUND OF THE INVENTION [0004] 1. Field of the Invention [0005] The present invention relates to nucleic acid segments having coding regions encoding enzymatically active hyaluronate synthase (HAS), and to the use of these nuclei...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): C12N1/21C12N9/10C12P19/26
CPCC12N9/1051C12P19/26
Inventor WEIGEL, PAULKUMARI, KSHAMA
Owner WEIGEL PAUL
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products